EPA:DIM - FR0013154002 - Common Stock
The current stock price of DIM.PA is 173.75 EUR. In the past month the price increased by 4.14%. In the past year, price decreased by -2.77%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 22.48 | 158.80B | ||
DAP.DE | DANAHER CORP | 26.57 | 122.53B | ||
LO3.DE | LONZA GROUP AG-REG | 37.31 | 43.26B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 42.92 | 17.25B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 44.4 | 14.46B | ||
ILU.DE | ILLUMINA INC | 23.54 | 12.88B | ||
SRT.DE | SARTORIUS AG | 36.32 | 11.83B | ||
ERF.PA | EUROFINS SCIENTIFIC | 17.73 | 11.63B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 17.66 | 11.58B | ||
QIA.DE | QIAGEN N.V. | 20.09 | 8.76B | ||
1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 22.37 | 3.27B | ||
TEN.DE | TECAN GROUP AG-REG | 31.67 | 2.15B |
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,030 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
SARTORIUS STEDIM BIOTECH
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
Aubagne PACA FR
Employees: 9961
Phone: 33442845600
The current stock price of DIM.PA is 173.75 EUR. The price increased by 1.64% in the last trading session.
The exchange symbol of SARTORIUS STEDIM BIOTECH is DIM and it is listed on the Euronext Paris - Matif exchange.
DIM.PA stock is listed on the Euronext Paris - Matif exchange.
18 analysts have analysed DIM.PA and the average price target is 239.39 EUR. This implies a price increase of 37.78% is expected in the next year compared to the current price of 173.75. Check the SARTORIUS STEDIM BIOTECH stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SARTORIUS STEDIM BIOTECH (DIM.PA) has a market capitalization of 16.91B EUR. This makes DIM.PA a Large Cap stock.
SARTORIUS STEDIM BIOTECH (DIM.PA) currently has 9961 employees.
SARTORIUS STEDIM BIOTECH (DIM.PA) has a support level at 168.86 and a resistance level at 174.37. Check the full technical report for a detailed analysis of DIM.PA support and resistance levels.
The Revenue of SARTORIUS STEDIM BIOTECH (DIM.PA) is expected to grow by 9.1% in the next year. Check the estimates tab for more information on the DIM.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SARTORIUS STEDIM BIOTECH (DIM.PA) has a dividend yield of 0.4%. The yearly dividend amount is currently 0.71. Check the full fundamental report for a detailed analysis of DIM.PA dividend history, reliability and sustainability.
SARTORIUS STEDIM BIOTECH (DIM.PA) will report earnings on 2025-10-16.
The PE ratio for SARTORIUS STEDIM BIOTECH (DIM.PA) is 42.07. This is based on the reported non-GAAP earnings per share of 4.13 and the current share price of 173.75 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DIM.PA.
ChartMill assigns a technical rating of 1 / 10 to DIM.PA. When comparing the yearly performance of all stocks, DIM.PA is a bad performer in the overall market: 85.09% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to DIM.PA. DIM.PA has only an average score on both its financial health and profitability.
Over the last trailing twelve months DIM.PA reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS increased by 25.91% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 7.78% | ||
ROA | 2.71% | ||
ROE | 5.63% | ||
Debt/Equity | 0.71 |
18 analysts have analysed DIM.PA and the average price target is 239.39 EUR. This implies a price increase of 37.78% is expected in the next year compared to the current price of 173.75.
For the next year, analysts expect an EPS growth of 27.61% and a revenue growth 9.1% for DIM.PA